About
Biomolecules acting as psychoneuroplastogens
Areas of Focus
Categories
Psychedelic
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
87
By Phase
PHASE1/PHASE2: 2PHASE1: 1
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06812221Lead Sponsor
Efficacy of Sublingual 5-MeO-DMT for Reducing Anxiety and Depression in MCI
PHASE1/PHASE2Completed
20 participants
Started: Dec 15, 2024 · Completed: Mar 15, 2025
NCT06816667Lead Sponsor
Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety
PHASE1/PHASE2Completed
40 participants
Started: Oct 21, 2024 · Completed: Mar 1, 2025
NCT05573568Lead Sponsor
Clinical Study of DMT in Healthy Adults
PHASE1Completed
27 participants
Started: Jun 1, 2022 · Completed: Nov 14, 2022
Locations (1)
Headquarters
Toronto, ON, Canada
Map
Loading map...